Literature DB >> 31667625

Elevated blood glucose is associated with aggravated brain edema in acute stroke.

Gabriel Broocks1, Andre Kemmling2,3, Jens Aberle4, Helge Kniep5, Matthias Bechstein5, Fabian Flottmann5, Hannes Leischner5, Tobias D Faizy5, Jawed Nawabi5,6, Gerhard Schön7, Peter Sporns2, Götz Thomalla8, Jens Fiehler5, Uta Hanning5.   

Abstract

BACKGROUND AND
PURPOSE: Clinical outcome after endovascular thrombectomy in patients with acute ischemic stroke still varies significantly. Higher blood glucose levels (BGL) have been associated with worse clinical outcome, but the pathophysiological causes are not yet understood. We hypothesized that higher levels of BGL are associated with more pronounced ischemic brain edema and worse clinical outcome mediated by cerebral collateral circulation.
METHODS: 178 acute ischemic stroke patients who underwent mechanical thrombectomy were included. Early ischemic brain edema was determined using quantitative lesion water uptake on initial computed tomography (CT) and collateral status was assessed with an established 5-point scoring system in CT-angiography. Good clinical outcome was defined as functional independence (modified Rankin Scale [mRS] score 0-2). Multivariable logistic regression analysis was performed to predict functional independence and linear regression analyses to investigate the impact of BGL and collateral status on water uptake.
RESULTS: The mean BGL at admission was significantly lower in patients with good outcome at 90 days (116.5 versus 138.5 mg/dl; p < 0.001) and early water uptake was lower (6.3% versus 9.6%; p < 0.001). The likelihood for good outcome declined with increasing BGL (odds ratio [OR] per 100 mg/dl BGL increase: 0.15; 95% CI 0.02-0.86; p = 0.039). Worse collaterals (1% water uptake per point, 95% CI 0.4-1.7%) and higher BGL (0.6% per 10 mg/dl BGL, 95% CI 0.3-0.8%) were significantly associated with increased water uptake.
CONCLUSION: Elevated admission BGL were associated with increased early brain edema and poor clinical outcome mediated by collateral status. Patients with higher BGL might be targeted by adjuvant anti-edematous treatment.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31667625     DOI: 10.1007/s00415-019-09601-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  41 in total

1.  Futile Recanalization With Poor Clinical Outcome Is Associated With Increased Edema Volume After Ischemic Stroke.

Authors:  Jawed Nawabi; Fabian Flottmann; Uta Hanning; Matthias Bechstein; Gerhard Schön; Andre Kemmling; Jens Fiehler; Gabriel Broocks
Journal:  Invest Radiol       Date:  2019-05       Impact factor: 6.016

2.  Exploratory analysis of glyburide as a novel therapy for preventing brain swelling.

Authors:  Kevin N Sheth; W Taylor Kimberly; Jordan J Elm; Thomas A Kent; Albert J Yoo; Götz Thomalla; Bruce Campbell; Geoffrey A Donnan; Stephen M Davis; Gregory W Albers; Sven Jacobson; Gregory del Zoppo; J Marc Simard; Barney J Stern; Pitchaiah Mandava
Journal:  Neurocrit Care       Date:  2014-08       Impact factor: 3.210

3.  'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs.

Authors:  W Hacke; S Schwab; M Horn; M Spranger; M De Georgia; R von Kummer
Journal:  Arch Neurol       Date:  1996-04

4.  Is There Enhanced Risk of Cerebral Ischemic Stroke by Sulfonylureas in Type 2 Diabetes?

Authors:  Fiona E Parkinson; Grant M Hatch
Journal:  Diabetes       Date:  2016-09       Impact factor: 9.461

5.  Increased admission and fasting glucose are associated with unfavorable short-term outcome after intra-arterial treatment of ischemic stroke in the MR CLEAN pretrial cohort.

Authors:  E Osei; H M den Hertog; O A Berkhemer; P S S Fransen; Y B W E M Roos; D Beumer; R J van Oostenbrugge; W J Schonewille; J Boiten; A A M Zandbergen; P J Koudstaal; D W J Dippel
Journal:  J Neurol Sci       Date:  2016-10-06       Impact factor: 3.181

6.  Clinical benefit of thrombectomy in stroke patients with low ASPECTS is mediated by oedema reduction.

Authors:  Gabriel Broocks; Uta Hanning; Fabian Flottmann; Michael Schönfeld; Tobias Djamsched Faizy; Peter Sporns; Michael Baumgart; Hannes Leischner; Gerhard Schön; Jens Minnerup; Götz Thomalla; Jens Fiehler; Andre Kemmling
Journal:  Brain       Date:  2019-05-01       Impact factor: 13.501

7.  Ischemic brain tissue water content: CT monitoring during middle cerebral artery occlusion and reperfusion in rats.

Authors:  Imanuel Dzialowski; Ernst Klotz; Sophia Goericke; Arnd Doerfler; Michael Forsting; Rüdiger von Kummer
Journal:  Radiology       Date:  2007-03-30       Impact factor: 11.105

8.  Glyburide is associated with attenuated vasogenic edema in stroke patients.

Authors:  W Taylor Kimberly; Thomas W K Battey; Ly Pham; Ona Wu; Albert J Yoo; Karen L Furie; Aneesh B Singhal; Jordan J Elm; Barney J Stern; Kevin N Sheth
Journal:  Neurocrit Care       Date:  2014-04       Impact factor: 3.210

9.  Impaired fasting glucose is associated with unfavorable outcome in ischemic stroke patients treated with intravenous alteplase.

Authors:  E Osei; S Fonville; A A M Zandbergen; P J Koudstaal; D W J Dippel; H M den Hertog
Journal:  J Neurol       Date:  2018-04-17       Impact factor: 4.849

10.  Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial.

Authors:  Kevin N Sheth; Jordan J Elm; Bradley J Molyneaux; Holly Hinson; Lauren A Beslow; Gordon K Sze; Ann-Christin Ostwaldt; Gregory J Del Zoppo; J Marc Simard; Sven Jacobson; W Taylor Kimberly
Journal:  Lancet Neurol       Date:  2016-08-23       Impact factor: 44.182

View more
  6 in total

1.  Association between pre-treatment perfusion profile and cerebral edema after reperfusion therapies in ischemic stroke.

Authors:  Felix C Ng; Leonid Churilov; Nawaf Yassi; Timothy J Kleinig; Vincent Thijs; Teddy Y Wu; Darshan Shah; Helen M Dewey; Gagan Sharma; Patricia M Desmond; Bernard Yan; Mark W Parsons; Geoffrey A Donnan; Stephen M Davis; Peter J Mitchell; Bruce Cv Campbell
Journal:  J Cereb Blood Flow Metab       Date:  2021-05-17       Impact factor: 6.200

2.  Aflibercept, a VEGF (Vascular Endothelial Growth Factor)-Trap, Reduces Vascular Permeability and Stroke-Induced Brain Swelling in Obese Mice.

Authors:  Il-Doo Kim; John W Cave; Sunghee Cho
Journal:  Stroke       Date:  2021-07-01       Impact factor: 7.914

3.  A J-Shaped Curve Relationship Between Baseline Fasting Blood Glucose and 1-Year Stroke Recurrence in Non-diabetic Patients With Acute Cerebral Infarction in Xi'an, China: A Multicenter Observational Cohort Study.

Authors:  Zhongzhong Liu; Xuemei Lin; Wenjuan Lin; Qingli Lu; Pei Liu; Jing Wang; Yan Liu; Qiaoqiao Chang; Yan Wang; Chensheng Song; Fang Wang; Yaling Shi; Qing Wang; Guozheng Liu; Ye Tian; Songdi Wu
Journal:  Front Neurol       Date:  2022-01-20       Impact factor: 4.003

4.  Effect of thrombectomy on oedema progression and clinical outcome in patients with a poor collateral profile.

Authors:  Helge Kniep; Uta Hanning; Gabriel Broocks; Andre Kemmling; Tobias Faizy; Rosalie McDonough; Noel Van Horn; Matthias Bechstein; Lukas Meyer; Gerhard Schön; Jawed Nawabi; Jens Fiehler
Journal:  Stroke Vasc Neurol       Date:  2020-11-18

5.  Interaction Effect of Baseline Serum Glucose and Early Ischemic Water Uptake on the Risk of Secondary Hemorrhage After Ischemic Stroke.

Authors:  Jawed Nawabi; Sarah Elsayed; Henriette Scholz; André Kemmling; Lukas Meyer; Helge Kniep; Matthias Bechstein; Fabian Flottmann; Tobias D Faizy; Gerhard Schön; Jens Fiehler; Uta Hanning; Gabriel Broocks
Journal:  Front Neurol       Date:  2021-07-08       Impact factor: 4.003

6.  Drug development in targeting ion channels for brain edema.

Authors:  Zheng-Wei Luo; Andrea Ovcjak; Raymond Wong; Bao-Xue Yang; Zhong-Ping Feng; Hong-Shuo Sun
Journal:  Acta Pharmacol Sin       Date:  2020-08-27       Impact factor: 6.150

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.